Floatz logo

A THERAPEUTIC PEGYLATED FIBROBLAST GROWTH FACTOR 21 AGONIST/MIMETIC WHICH RESTORES LEPTIN RESPONSIVENESS

Liver Fibrosis

Bristol-Myers Squibbprotein_peptidePhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

27 Active assets in the Liver Fibrosis cohort.

Asset / SponsorPhaseRating
Entecavir
Tanta University
Phase 4BB
Peg-Intron
Beth Israel Deaconess Medical Center
Phase 4BB
COLCHICINUM
Zagazig University
Phase 4BB
Peg-Ifn
Beijing Friendship Hospital
Phase 4BB
Ribavirin
ANRS, Emerging Infectious Diseases
Phase 3BB

View all 50 →

Same molecule, other indications

A THERAPEUTIC PEGYLATED FIBROBLAST GROWTH FACTOR 21 AGONIST/MIMETIC WHICH RESTORES LEPTIN RESPONSIVENESS is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative ·
70 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
69 / 100
View asset →
Nonalcoholic Fatty Liver DiseaseDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →